Revision of USP Chapter on IR Spectroscopy
Recommendation
13-15 October 2026
Barcelona, Spain
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In the Pharmacopeial Forum No 39(2), the USP has published the draft for the revised General Chapter <854> on Mid-Infrared Spectroscopy. This draft is the second one and takes into consideration the comments sent to the USP.
Some acceptance criteria for some of the single validation parameters have been adapted in the validation of IR methods. Regarding accuracy, the recovery rate has been added to 95.0% - 105.0% for drug product assay.
Regarding precision, the relative standard deviation for repeatability is set as follows:
- Not more than 1.0% for APIs
- Not more than 2.0% for medicinal products
- Not more than 20.0% for impurities
And for intermediate precision:
- Not more than 1.0% for APIs
- Not more than 3.0% for medicinal products
- Not more than 25.0% for impurities
In addition to revised Chapter <854>, there will also be the new General USP Chapter <1854> which describes theory and practice of Mid Infrared Spectroscopy.
Both documents can be found on the Pharmacopeial Forum of the USP website.
Related GMP News
05.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus
05.10.2026Pharmeuropa: Revision Proposed for Chapter 2.5.32 on Coulometric Karl Fischer Water Determination
30.09.2026The Relationship between the BP and the Ph. Eur.
30.09.2026New Japanese Pharmacopoeia Drafts (September 2026) Open for Public Comment
30.09.2026EMA publishes final ICH M13B Guideline and Q&A on Bioequivalence